Updated ACS guidance suggests use in those who decline other options ...

The American Cancer Society updated its colorectal cancer screening guideline to reflect molecular-based screening tests that ...

A systematic review was conducted to examine the potential impact of new molecular‐based screening tests on CRC incidence and mortality.

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

The American Cancer Society updated its colorectal cancer screening guidelines to include additional blood- and stool-based screening options, while reaffirming that average-risk adults should begin ...

Development of custom amplicon-based test systems for detecting KRAS, NRAS, and BRAF gene mutations in colorectal cancer using next-generation sequencing (NGS). This is an ASCO Meeting Abstract from ...

A new perspective paper explores the current state and future directions of precision medicine in colorectal cancer (CRC). It outlines advancements in molecular testing and their implications for ...

CT screening for lung cancer could save countless lives, but low participation rates have led to some eyebrow-raising proposals. Molecular methods, touted by those with a vested interest, promise to ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...